Pluvicto (lutetium LU 177 vipivotide tetraxetan)
Ended Awarded Last action
- Contract number
- 36C25524A0025
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 2 $595,344 obligated
Award facts
- Opportunity
-
- 6505--Intent to Sole Source PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) Special Notice · 36C25524Q0268 · Posted Mar 21, 2024
- Combined order value
- $595,344 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 40% used
- $1,493,220.26
- Maximum order
- $20,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 15 has awarded a Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The BPA, valued at $1,493,220.26, is for the delivery of the radiopharmaceutical product PLUVICTO (Lutetium Lu 177 Vipivotide Tetraxetan) over the contract period ending July 31, 2025.
Advanced Accelerator Applications USA Inc. is a subsidiary of Novartis and specializes in developing and producing advanced nuclear medicine products. The company has been actively supplying radiopharmaceuticals to federal healthcare agencies like the VA, Defense Health Agency, and National Institutes of Health through various contract vehicles, primarily under the Pharmaceuticals and Drugs Federal Supply Schedule. This BPA award, which includes a $746,610.13 firm fixed price call order, will enable the VA to efficiently procure the PLUVICTO product for use in cancer treatment and diagnostic imaging at its medical facilities nationwide.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pluvicto (lutetium LU 177 vipivotide tetraxetan) extension | Veterans Integrated Service Network 15 (VHA) | $166,146 | |
| Pluvicto (lutetium LU 177 vipivotide tetraxetan) | Veterans Integrated Service Network 15 (VHA) | $429,198 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C25524A0025?
36C25524A0025 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on March 28, 2024.
How much is contract 36C25524A0025 worth?
Orders under 36C25524A0025 have obligated $595,344. 36C25524A0025's own ceiling is $1,493,220. A single order can be worth up to $20,000.
How many orders have been placed under contract 36C25524A0025?
2 orders have been placed under 36C25524A0025, the latest on March 28, 2025.
Who can order from contract 36C25524A0025?
36C25524A0025 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36C25524A0025 under another contract?
Yes. 36C25524A0025 is a blanket purchase agreement under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25524A0025 competed?
The extent of competition for 36C25524A0025 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV